Live feed
Filing
SC 13D/A
SC 13D/A0000903423-18-000105·CRISPR Therapeutics AG
Schedule 13D ownership disclosure
CRISPR Therapeutics AG
Security class unavailable · CUSIP: H17182108
Event date: 2018-01-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,265,627
- Percent of class
- 7.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-18-000105
- Form type
- SC 13D/A
- Filer
- CRISPR Therapeutics AG
- CIK
- CIK 1674416
- Filed
- Feb 13, 2018
- Reporting period
- Jan 09, 2018
- Description
- Schedule 13D beneficial ownership